← Leaderboards
Srividya Bhaskara
Vanderbilt University
$1,831,676
Attributed
$1,831,676
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $361.3K · FY2009–19$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,831,676 · 2
By mechanism
R01$1,737,589 · 1
F32$94,087 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Scott Hiebert$33,340,607
- Michael E Engel$2,768,546
- Alyssa R Summers$148,182
- Abigail Smith$52,920
- Madelaine Paige Thorpe$53,348
Others in their field
Top investigators on “Histone Deacetylase Inhibitor”
- Walter John Curran · Thomas Jefferson University$26,641,549
- Douglas F Nixon · J. David Gladstone Institutes$22,465,802
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$20,489,538
- Steven A Belinsky · Lovelace Biomedical &Environmental Res$10,179,089
- Joel M. Gottesfeld · Scripps Research Institute$9,293,030
- Timothy McKinsey · University Of California Los Angeles$9,068,650
Research focus
Histone Deacetylase InhibitorInhibitor/AntagonistDna DamageHistone AcetylationCellsHistonesDesignCell CycleEpigenetic ProcessGenome StabilityAcetylationAffectChimeric ProteinsCell DeathChromatinChromatin StructureApoptosisBaseB-Cell DevelopmentDna RepairGene ExpressionGenetic TranscriptionB-LymphocytesKnockout Mice
Grant awards (9)
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy$330,612
R01 · FY2019 · CA · contact PI
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy$23,153
R01 · FY2019 · CA · contact PI
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy$340,838
R01 · FY2018 · CA · contact PI
Histone deacetylases 1,2 and DNA repair$20,472
R01 · FY2018 · CA · contact PI
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy$340,838
R01 · FY2017 · CA · contact PI
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy$340,838
R01 · FY2016 · CA · contact PI
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy$340,838
R01 · FY2015 · CA · contact PI
In vivo and in vitro roles played by Hdac3 in genomic stability maintenance$38,777
F32 · FY2010 · CA · contact PI
In vivo and in vitro roles played by Hdac3 in genomic stability maintenance$55,310
F32 · FY2009 · CA · contact PI